Teamshares is an employee ownership platform tailored for small businesses, utilizing proprietary software, education, and financial products. Acknowledging small businesses as economic powerhouses and community pillars, Teamshares aims to ensure their continuity. The goal is to build a network of 10,000 financially durable, employee-owned small businesses across America, fostering a new era of business ownership and financial resilience.

Register for Details

For more details on financing and valuation for Verge Genomics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Verge Genomics

Forge green plus iconForge green minus icon

What is Verge Genomics's IPO price?

The IPO price for Verge Genomics will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Verge Genomics?

Verge Genomics is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Verge Genomics shares pre-IPO?

If you own Verge Genomics pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Verge Genomics a publicly traded company?

Verge Genomics is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

What is Verge Genomics's funding to date?

Verge Genomics has raised $180.65MM to date.
Forge green plus iconForge green minus icon

When was Verge Genomics founded?

Verge Genomics was founded in 2015.

Verge Genomics funding rounds and last known valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation

Series C

$42MM raised $XXX.XX $XXX.XX

Series B-1

$85MM raised $XXX.XX $XXX.XX

Series A-1

$45.12MM raised $XXX.XX $XXX.XX

Series A-2 and A-3

$7.91MM raised $XXX.XX $XXX.XX

Series A-4, A-5 and A-6

$620K raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: Jun 24, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.